Read all posts
www.nytimes.com

New Drug to Treat Obesity Gains Approval by F.D.A.

Medicare, most state Medicaid programs and some commercial insurers do not pay for the drugs. Doctors and patients are cautious about safety because of problems with previous weight loss drugs. And for many people, the weight loss is modest.

Read the article on Nytimes

Dr. Sears Comments:

Dr. Barry Sears

The reason why the first two new obesity drugs have not sold well is because they don’t work effectively. This new drug should be no different. The only obesity drug that sold well was Fen-Phen because it shut down appetite very effectively. Of course, it had a few side effects like death, but it worked very well in those who didn’t die.

Leave a Reply

Your email address will not be published. Required fields are marked *